CHENNAI PLUS

Vi, India’s leading telecom operator has  announced a significant capacity addition by integrating ‘Vi Movies & TV App’ into the ‘Vi App’, which now allows customers to stream their favourite content seamlessly. Offering a simplified and new user experience, Vi App will now double up as an OTT app offering a rich repertoire of content, in addition to the wide range of products & services available. Vi subscribers can now access robust content on Vi App from:   450+ Live TV channels including the likes of Zee TV, Zee Cinema, Colors HD, Colors Infinity, Discovery, MTV, History TV, SunTV, Zee Bangla, Animal Planet, Nick & many more.    Live News on channels like Aaj Tak, India TV, CNBC Awaaz, Republic TV, ABP News, NDTV 24x7, CNN News & many more. Premium content from OTT apps like Voot Select, Discovery, Lionsgate Play, SunNxt and Shemaroo Me The integrated experience is now live for Android users and will soon be available for iOS users. You can download the App via:

Belstar Microfinance Limited, a subsidiary of Muthoot Finance Limited (Muthoot Group) has signed definitive agreements to raise primary equity of Rs. 350 crore from new investor Affirma Capital and existing investors Muthoot Finance and Maj Invest.   This equity raise is subject to obtaining required regulatory approvals. An equity raise by Belstar during these pandemic times is a testimony of their asset quality and sustained efforts in woman empowerment, poverty alleviation coupled with community development. Ever since Muthoot Group’s initial capital infusion of Rs.55.40 Cr in 2016 for 57.16% stake, Belstar has grown leaps and bounds expanding its branch network to 650 in 19 states with over Rs.3,100 Cr AUM and upgrading its rating from CARE BBB- to CRISIL AA-. This round of funding is being led by funds advised by Affirma Capital who will invest Rs.300 cr out of a total round of Rs 350 cr. Affirma Capital manages over US$3.5 billion in assets for leading global limited partners

Indian Bank has been featured in the Harvard Business Publishing for its successful merger of Allahabad Bank. The first-of-its-kind seamless merger of equal sized Indian banks with prominence in the southern and eastern region of the country has been well recognized and published by Harvard Business Publishing as a case study. Curated by Indian School of Business (ISB), this unique case study titled ‘Merger of Equals: The Amalgamation Story of Indian Bank and Allahabad Bank’ encapsulates the remarkable journey that Indian Bank embarked on, to successfully execute the amalgamation process. ‘Merger of Equals’ narrates the entire integration process which comprised of rigorous strategic planning and execution by Indian Bank, with impetus on the challenges faced and their answers found. The merger has made Indian Bank, a pan-India lender with significant presence in southern, northern and eastern parts of the country. The amalgamation exercise ‘Project Sangam’ had a three-pronged app

Chennai, August 20, 2021 : The Common Services Centers, under the Ministry of Electronics & IT, has partnered with Vodafone Idea Foundation, the CSR arm of Vi, for registration of citizens to receive vaccination against the deadly COVID-19 virus. The initiative will focus on vulnerable and disadvantaged communities. The CSC Academy, the CSR & Education wing of CSC, will facilitate registration and scheduling of one million beneficiaries for vaccination across the country through the Village Level Entrepreneurs (VLEs). The VLEs will act as a focal point for identifying and reaching out to ageing population, slum dwellers, daily wage workers, etc. Elaborating on the partnership, Dr. Dinesh Tyagi, Managing Director, CSC SPV, said: “CSC has always stepped in to support social initiatives undertaken for the benefit of citizens. Registration of citizens on CoWin App is one such activity that CSC has undertaken as part of our commitment to provide inclusive healthcare to all. Our

At a special ceremony held at the Indian Embassy in Riyadh, Eram Group Chairman and Managing Director Dr. Siddeek Ahmed, was officially presented with the 2021 Pravasi Bharatiya Samman Award (PBSA) by the Ambassador of India to the Kingdom of Saudi Arabia, H.E. Dr. Ausaf Sayeed. This year, Dr. Ahmed was one of only 4 recipients from the Middle East and the only one representing the Kingdom.   The pandemic didn’t allow for the more elaborate ceremony that is usually held in New Delhi annually every year, but the sense of occasion and sentiment was palpable at the embassy. Eram Group’s interests in India remain far and wide and the company employs 2000+ across 5 states who focus primarily on developing indigenous technology tailored to local requirements primarily in the sanitation space via a R&D-based social enterprise , Eram Scientific Solutions, acquired by Dr Ahmed in the year 2011. The innovative 'e-Toilet', which is an automated public sanitation solution in line wit

Apollo Children’s Hospital had successfully performed Vein Of Galen Malformation (VOGM) surgery with an excellent outcome on a 2 day old baby. The parents of the baby during a press conference held on 18 th August 2021 at Apollo Children’s Hospital Thousand Lights, Chennai, thanked Suneeta Reddy is the Managing Director of Apollo Hospitals, Dr.Srinivasan and team of doctors for their caring support and saving their baby, a precious gift from God.  A vein of Galen malformation (VOGM) is a type of rare blood vessel abnormality inside the brain. In VOGM, misshapen arteries in the brain connect directly with veins, instead of connecting with capillaries, which help slow blood flow. This causes a rush of high-pressure blood into the veins.

In a first of its kind initiative, the Apollo Hospitals Group, Asia’s largest and most trusted healthcare group signed a MOU with Group of Hospitals - DMIMS, DU, one of the biggest private healthcare Medical University in India to bring their world-class liver transplant program to patients in Central India. The two institutions would work to build a successful liver transplant program that brings the best of medical expertise and the latest world-class technological advances in liver transplant care to Central India. The MOU, signed on World Organ Donation Day, would benefit patients with complications due to end-stage chronic liver disease as also in rare cases of sudden failure of a previously healthy liver. The MOU was signed by Dr. Anupam Sibal, Group Medical Director- Apollo Hospitals Group and Dr. Sandeep Shrivastava, CEO, Group of Hospitals - DMIMS, DU   Ms. Sangita Reddy, Joint Managing Director, Apollo Hospitals said, “This MOU is the first of its kind in the Central India

Vi, India’s leading telecom operator, extended its flagship RedX offering to RedX Family, a unique postpaid experience, as families depend on a seamless mobile experience to stay connected and meet their daily needs. As more and more members of a family are consuming higher data due to WFH, online schooling, entertainment and online socializing, this plan is designed to cater to their needs offering unlimited data for all members, entertainment and travel benefits – all under a single bill.       Priced at Rs 1699 and Rs 2299, Vi RedX Family Plan allows consumers to add up to 3 and 5 family members respectively. Along with unlimited 4G data on every connection, Vi RedX Family Plan offers the benefits of the Vi RedX plan which includes host of benefits on entertainment, travel and more.   The primary member can avail membership of OTT platforms like Netflix, Amazon Prime and Disney+ Hotstar along with VIP access to Vi Movies & TV. The plan also provides a complimentary Internati

At a time when vaccinations for children are still being tested, Jammi Pharmaceuticals had launched a purely Ayurvedic immunity booster, " Yummunity", on 6 th August 2021 for children which marks 'A Break-through Innovation to boost your Child's Immunity during these challenging times’ event. Global Indian Ambassador of Women Entrepreneurship-UN, Dr Madhu Saran Vel was the chief guest.   Speaking at the event, Dr. Narasimham V Jammi, Managing Director of Jammi Pharmaceuticals Pvt. Ltd. said, "Ayurveda is now a necessity and the world can no longer ignore it. I strongly endorse the exclusive use of Ayurveda for building immunity as well as treating lifestyle diseases."   Dr Narasimham has authored a book titled 'The Orphan's Father: Ayurveda - Curing Modern Medicine's Abandoned Diseases'. The book was released during the event. Dr. Narasimham further said that this book will help people understand the importance of Ayurveda and how the t

HFCL is pleased to announce the signing up of a nationwide distribution agreement with Beetel Teletech (Beetel) for its ‘IO’ line of next generation products. Under this agreement, Beetel, as the National Distributor, will be marketing HFCL’s complete portfolio of products under ‘IO’ brand. These include latest generation Wi-Fi 5 and Wi-Fi 6 Access Points, P2P & P2MP Unlicensed Band Radios, L2 & L3 Switches, and highly specialized antennas.  Signing up of this distribution agreement, on the back of successful shipment of 150,000+ ‘IO’ units within the first 12 months of its launch, is aimed at twin-fold gains. On the one hand, it is going to strengthen HFCL’s product distribution network for the existing and future product lines. On the other hand, it is aimed at accelerating expansion of market share for maturing products while reducing the time to market for recently launched and to be launched products.  Launched in October 2019, ‘IO’ is HFCL’s industry leading brand of

Apollo Hospitals, Asia's foremost and most trusted healthcare group, on 4 th August 2021 had announced a successful MitraClip implant on a 41-year-old male farmer who had waited for over three months in different hospitals for a heart transplant. The patient was back on his feet within a few days after the procedure, and might not even need a heart transplant. Dr. Sai Satish, Senior Interventional Cardiologist, Apollo Hospitals said, “The MitraClip is a small metal clip with a polyester fabric that is inserted in place to fix the leaky mitral valve thereby ensuring that the blood flow is in the right direction. It is a globally accepted procedure for patients with heart failure. Patients with moderate to severe or severe primary and secondary mitral regurgitation who are not improving on medical treatment can opt for this minimally invasive solution that offers them a vastly improved quality of life and health. For three years now we have been performing this procedure on patien